Alume Biosciences

Alume Biosciences is a clinical-stage biotechnology company in La Jolla, California, developing nerve-targeted fluorescent agents for precision surgery. Its lead candidate, bevonescein (ALM-488) — a peptide-dye conjugate co-invented by the late Nobel Laureate Dr. Roger Tsien and surgeon Dr. Quyen Nguyen — is administered intravenously roughly an hour before an operation so surgeons can see nerves illuminated in the surgical field and avoid inadvertent nerve injury. The compound has FDA Fast Track designation, is in Phase 3 pivotal trials in head-and-neck surgery, and the company has stated it plans a New Drug Application submission in 2026. Alume is a drug developer, not a software vendor: it publishes no developer program, API, SDK or machine-readable specification.

Alume Biosciences is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Life Sciences, Pharmaceuticals, and Clinical Trials.

Alume Biosciences’ developer surface includes engineering blog and 8 more developer resources.

🌐 Visit website 📡 Source on GitHub

6.4/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-08-17 · rubric v0.11.0

0 APIs

CompanyBiotechnologyLife SciencesPharmaceuticalsClinical TrialsSurgeryMedical ImagingHealth

Kin Score

Kin Score How this is scored →
scored 2026-08-17 · rubric v0.11.0

Composite quality — 6.4/100 · minimal

Contract Quality 0.0 / 21

Developer Ergonomics 0.4 / 17

Commercial Clarity 0.0 / 17

Operational Transparency 0.0 / 11

Governance 0.0 / 10

Discoverability 4.9 / 9

Regulatory Posture 1.1 / 15

Agent readiness — 0/100 · human only

Machine-Readable Contract 0 / 18

Agentic Access Contract 0 / 10

MCP Server 0 / 12

Machine-Readable Auth 0 / 10

Idempotency 0 / 9

Stable Error Semantics 0 / 8

Request/Response Examples 0 / 7

Rate-Limit Signaling 0 / 7

Typed Event Surface 0 / 6

Agent Skills 0 / 5

Well-Known Catalog 0 / 4

Consent & Bot Identity 0 / 3

A2A Agent Card 0 / 8

Dry-Run / Simulate Mode 0 / 4

Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.

The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/alume-biosciences: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Agent Surfaces 1

MCP servers, agent skills, and machine-readable catalogs

LLMsTxt

LLMsTxt

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity

DomainSecurity

Operate 1

Status, limits, changes, and where to get help

Contact

Contact

Company 6

The organization behind the API

Website

About

Blog

Careers

Twitter

Instagram

Source (apis.yml)

aid: alume-biosciences
name: Alume Biosciences
description: 'Alume Biosciences is a clinical-stage biotechnology company in La Jolla, California, developing nerve-targeted
  fluorescent agents for precision surgery. Its lead candidate, bevonescein (ALM-488) — a peptide-dye conjugate co-invented
  by the late Nobel Laureate Dr. Roger Tsien and surgeon Dr. Quyen Nguyen — is administered intravenously roughly an hour
  before an operation so surgeons can see nerves illuminated in the surgical field and avoid inadvertent nerve injury. The
  compound has FDA Fast Track designation, is in Phase 3 pivotal trials in head-and-neck surgery, and the company has stated
  it plans a New Drug Application submission in 2026. Alume is a drug developer, not a software vendor: it publishes no developer
  program, API, SDK or machine-readable specification.'
image: https://alumebiosciences.com/wp-content/uploads/2019/08/apple-icon-180x180.png
url: https://raw.githubusercontent.com/api-evangelist/alume-biosciences/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-tier: stub
x-tier-reason: harvest
specificationVersion: '0.20'
created: '2026-08-06'
modified: '2026-08-06'
tags:
- Company
- Biotechnology
- Life Sciences
- Pharmaceuticals
- Clinical Trials
- Surgery
- Medical Imaging
- Health
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: Website
  url: https://alumebiosciences.com/
- type: About
  url: https://alumebiosciences.com/about-us/
- type: Blog
  url: https://alumebiosciences.com/news/
- type: Contact
  url: https://alumebiosciences.com/contact/
- type: Careers
  url: https://alumebiosciences.com/careers/
- type: Twitter
  url: https://twitter.com/alumebioscience
- type: Instagram
  url: https://instagram.com/alumebiosciences
- type: DomainSecurity
  url: security/alume-biosciences-domain-security.yml
- type: LLMsTxt
  url: llms/alume-biosciences-llms.txt
x-enrichment:
  date: '2026-08-06'
  status: minimal
  artifacts_added: 3
  pass: local-v1
x-coverage:
  state: none
  reason: not-a-software-company
  detail: Alume Biosciences is a clinical-stage drug developer whose entire web presence is a five-page WordPress marketing
    site (about, news, careers, contact) with no developer, API or documentation section anywhere in its sitemap; the only
    machine-readable endpoint on the host is the default WordPress /wp-json/ CMS route index, which is site infrastructure
    and not a published API product.
  evidence:
  - url: https://alumebiosciences.com/openapi.json
    status: 404
  - url: https://alumebiosciences.com/.well-known/agent-card.json
    status: 404
  - url: https://alumebiosciences.com/llms.txt
    status: 404
  - url: https://alumebiosciences.com/wp-sitemap-posts-page-1.xml
    status: 200
  - url: https://github.com/alumebio
    status: 404
  checked: '2026-08-06'